Blog

Reforming Outdated Barriers to Research on Mental Health and Addiction Treatment

Written by Bridget McQuillan and Jazz Glastra "As a researcher, I always hesitate to go into doing research with Schedule I drugs,” said Dr. Nora Volkow, Director of the National Institute on Drug Abuse, or NIDA, in 2021 (Jager, 2021). NIDA, part of the federal government’s National Institutes of Health, funds and conducts billions of dollars’ wort...

Event Announcement: Welcome to the Future of Rapid-Acting Mental Health Treatments

On May 18, join BrainFutures and the Frontier Psychiatrists at Rapid-Acting Mental Health Treatment (RAMHT 2025) in Los Angeles, CA, as we explore the latest developments in rapid-acting treatments for mental health. The event takes place at the Skyline Loft on the second night of the American Psychiatric Association annual conference less than a mile from the co...

Live Provider Roundtable: Integrating Psychedelic Therapies into Healthcare

Save the Date! BrainFutures is excited to invite you to a Virtual Provider Roundtable on April 1st at 12 PM EST / 9 AM PST. Click here to register now to join the conversation!  This session is a follow-up to BrainFutures and the Collaborative of the Economics for Psychedelics’ new whitepaper, Scaling Psychedelics in the Health System. This roundtable w...

New Healthcare Provider Survey Reveals Both Opportunities and Barriers in Planned Adoption of Psychedelic Therapy

New Healthcare Provider Survey Reveals Both Opportunities and Barriers in Planned Adoption of Psychedelic Therapy  Health providers plan rapid adoption of psychedelic therapy, but anticipate delays in insurance coverage  LUTHERVILLE, MD AND BERKELEY, CA – March 10, 2025 – A survey of mental health providers from 15 states revealed both opportunities a...

Dr. Bruce Wexler on the ACTIVATE™ Program and its Breakthrough Impacts on Youth Executive Function

Dr. Bruce Wexler is Professor Emeritus at Yale University as well as a member of the BrainFutures Advisory Board. BrainFutures has partnered with Dr. Bruce E. Wexler of Yale University and the Howard County Public School System to implement ACTIVATE™, an evidence-based executive function intervention, across 12 schools in Howard County, Maryland. ACTIVATE...

Introducing Sarah Norman, BrainFutures' New Executive Director

BrainFutures is pleased to introduce our new Executive Director, Sarah Norman, who comes to us with deep experience in health policy, healthcare delivery systems, multistakeholder coalitions, and organizational leadership. Sarah brings more than two decades of strategic operations, policy and leadership experience in the healthcare field. As Chief of Communi...

New NORC/BrainFutures Study Finds Psychedelics in Healthcare Practitioner Training is Growing

New NORC/BrainFutures Study Finds Psychedelics in Healthcare Practitioner Training is Growing Research gauged level of clinician workforce preparedness and education in anticipation of possible FDA approval for psychedelic therapies CHICAGO and LUTHERVILLE, MD – December 11, 2024 – In a comprehensive survey of academic leaders from counseling, social work...

BrainFutures' Response to the Psychedelics Advancing Therapies (PATH) Caucus's Request for Information on Psychedelic Medicine

The bipartisan PATH Caucus is seeking feedback on how to create policies and programs for emerging therapies involving psychedelic or entactogenic substances in medically supervised, supportive settings. They aim to better inform Congressional members by educating them about innovative, evidence-based therapies involving psychedelics, as well as the consideration...

Highlights from April 2024

Congressional Task Force Briefing On April 9th, BrainFutures hosted a comprehensive briefing on medical psychedelic-assisted therapy for congressional staffers in partnership with the Bipartisan Mental Health and Substance Use Disorder Task Force. Our discussion spanned a wide range of topics including the science and history behind psychedelics, the model of ...

Letter from BrainFutures’ Interim Executive Director: Mental Health Parity, Policy, and PAT Training

Today, BrainFutures is proud to announce the release of our latest issue brief, A Path Toward Parity: Ensuring Equitable Access to Psychedelic-Assisted Therapy. This paper helps stakeholders understand how the 2008 Mental Health Parity and Addiction Equity Act (MHPAEA) can be used as a key lever to ensure widespread insurance coverage for psychedelic-assisted the...